Uric Acid and Arterial Stiffness
- PMID: 32095074
- PMCID: PMC6995306
- DOI: 10.2147/TCRM.S232033
Uric Acid and Arterial Stiffness
Abstract
Hyperuricemia is usually associated with hypertension, diabetes mellitus, metabolic syndrome and chronic kidney disease. Accumulating data from epidemiological studies indicate an association of increased uric acid (UA) with cardiovascular diseases. Possible pathogenic mechanisms include enhancement of oxidative stress and systemic inflammation caused by hyperuricemia. Arterial stiffness may be one of the possible pathways between hyperuricemia and cardiovascular disease, but a clear relationship between increased UA and vascular alterations has not been confirmed. The review summarizes the epidemiological studies investigating the relationship between UA and arterial stiffness and highlights the results of interventional studies evaluating arterial stiffness parameters in patients treated with UA-lowering drugs.
Keywords: arterial stiffness; cardiovascular risk; uric acid.
© 2020 Albu et al.
Conflict of interest statement
The authors report no other conflicts of interest in this work.
Figures
Similar articles
-
Uric Acid, Vascular Stiffness, and Chronic Kidney Disease: Is There a Link?Blood Purif. 2017;43(1-3):189-195. doi: 10.1159/000452726. Epub 2017 Jan 24. Blood Purif. 2017. PMID: 28114139 Review.
-
Hyperuricemia and the progression of chronic kidney disease: is uric acid a marker or an independent risk factor?Adv Chronic Kidney Dis. 2012 Nov;19(6):386-91. doi: 10.1053/j.ackd.2012.05.004. Adv Chronic Kidney Dis. 2012. PMID: 23089273 Review.
-
Effect of uric acid serum levels on carotid arterial stiffness and intima-media thickness: A high resolution Echo-Tracking Study.Monaldi Arch Chest Dis. 2019 Mar 27;89(1). doi: 10.4081/monaldi.2019.1007. Monaldi Arch Chest Dis. 2019. PMID: 30968661
-
Uric acid and cardiovascular disease.Clin Chim Acta. 2018 Sep;484:150-163. doi: 10.1016/j.cca.2018.05.046. Epub 2018 May 24. Clin Chim Acta. 2018. PMID: 29803897 Review.
-
The uric acid metabolism pathway as a therapeutic target in hyperuricemia related to metabolic syndrome.Expert Opin Ther Targets. 2012 Dec;16(12):1175-87. doi: 10.1517/14728222.2012.723694. Epub 2012 Sep 28. Expert Opin Ther Targets. 2012. PMID: 23020656 Review.
Cited by
-
The Role of Oxidative Stress in Hyperuricemia and Xanthine Oxidoreductase (XOR) Inhibitors.Oxid Med Cell Longev. 2021 Mar 26;2021:1470380. doi: 10.1155/2021/1470380. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 33854690 Free PMC article. Review.
-
Does Serum Uric Acid Status Influence the Association Between Left Atrium Diameter and Atrial Fibrillation in Hypertension Patients?Front Cardiovasc Med. 2020 Nov 27;7:594788. doi: 10.3389/fcvm.2020.594788. eCollection 2020. Front Cardiovasc Med. 2020. PMID: 33330657 Free PMC article.
-
Mutual effect of homocysteine and uric acid on arterial stiffness and cardiovascular risk in the context of predictive, preventive, and personalized medicine.EPMA J. 2022 Sep 26;13(4):581-595. doi: 10.1007/s13167-022-00298-x. eCollection 2022 Dec. EPMA J. 2022. PMID: 36505895 Free PMC article.
-
Metabolomics of Arterial Stiffness.Metabolites. 2022 Apr 20;12(5):370. doi: 10.3390/metabo12050370. Metabolites. 2022. PMID: 35629874 Free PMC article. Review.
-
The Association between Serum Resistin Level, Resistin (-420C/G) Single Nucleotide Variant, and Markers of Endothelial Dysfunction, including Salt Taste Preference in Hypertensive Patients.Nutrients. 2022 Apr 24;14(9):1789. doi: 10.3390/nu14091789. Nutrients. 2022. PMID: 35565757 Free PMC article.
References
-
- Wang JG, Staessen JA. Raised concentrations of serum creatinine and uric acid and the risks of mortality and cardiovascular disease. Cardiovasc Rev Rep. 2002;23:393–399.
Publication types
LinkOut - more resources
Full Text Sources